AI-Read Electrocardiogram Screening for Pulmonary Hypertension
Tests an AI-read electrocardiogram to screen adults aged 50 to 85 for pulmonary hypertension.
Plain-language title generated from the registry record
Registry title: A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
Key facts
- Where
- Taipei, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 85 years old?
Source: NCT07079592, who can take part
Where in Taiwan
- National Defense Medical CenterTaipei, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Defense Medical Center, Taiwan
- Trial code
- NCT07079592
- Record updated
- 24 February 2026
- Original description
This study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation through echocardiography, potentially resulting in improving cardiovascular outcomes.Read full original descriptionShow less
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension: A Randomized Controlled Trial
This study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation through echocardiography, potentially resulting in improving cardiovascular outcomes.
Inclusion: Men or women, ≥ 50 to 85 years of age; At least one 12-lead ECG within 3 months.
Exclusion: Prior heart, lung, or heart-lung transplants; Echocardiography in 3 months before index ECG; A diagnosis of hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, cardiac amyloidosis, or infiltrative cardiomyopathy; A diagnosis of PH WHO Groups 1, 2, 3, 4, or 5; Any systolic pulmonary artery pressure >50 mmHg by echocardiography before.